Heart Disease Clinical Trials in Dallas

Showing 141-160 of 219 trials

Effectiveness of NephroCheckTM Test to Predict Acute Kidney Injury Following Advanced Cardiac Replacement Therapies

NCT02827448

The purpose of this study is to test how well the NephroCheckTM Test, a noninvasive laboratory test performed on urine, predicts loss of kidney function in patients that have had a heart transplant or a Left Ventricular Assist Device (LVAD) or Total Artificial Heart (TAH) implanted.

Acute Kidney InjuryHeart Failure

Baylor Research Institute300 participantsStarted Nov 2015

Dallas, Texas, United States

TERMINATEDPHASE3< 1 mile

The Evaluation of Bococizumab (PF-04950615; RN316) in Reducing the Occurrence of Major Cardiovascular Events in High Risk Subjects

NCT01975389

This study evaluates the PCSK9 inhibitor, Bococizumab (PF-04950615;RN316), compared to placebo, in reducing the occurrrence of major cardiovascular events, including cardiovascular death, myocardial infarction, stroke, and unstable angina requiring urgent revascularization in high risk subjects who are receiving background lipid lowering therapy and have cholesterol laboratory values of LDL-C \>/= 100 mg/dL (2.6 mmol/L) or non-HDL-C \>/=130 mg/dL (3.4 mmol/L).

Cardiovascular Disease

Pfizer10,564 participantsStarted Oct 2013

Athens, Alabama, United States • Athens, Alabama, United States • Birmingham, Alabama, United States +1592 more locations

Effectiveness of NephroCheckTM Test to Predict Acute Kidney Injury Following Advanced Cardiac Replacement Therapies

The Evaluation of Bococizumab (PF-04950615; RN316) in Reducing the Occurrence of Major Cardiovascular Events in High Risk Subjects

Heart Disease Trials in Other Cities

ODYSSEY Outcomes: Evaluation of Cardiovascular Outcomes After an Acute Coronary Syndrome During Treatment With Alirocumab

Targeting Acute Congestion With Tolvaptan in Congestive Heart Failure

Naltrexone/Bupropion Cardiovascular Outcomes Study

Effect of Pexelizumab on All-Cause Mortality and Myocardial Infarction in Patients Undergoing Coronary Artery Bypass Graft Surgery With Cardio-Pulmonary Bypass

DF4 Connector System Post-Approval Study

Comparing the Effectiveness of Repairing Versus Replacing the Heart's Mitral Valve in People With Severe Chronic Ischemic Mitral Regurgitation

NAVISTAR® THERMOCOOL® Catheter for the Radiofrequency Ablation of Symptomatic Paroxysmal Atrial Fibrillation

Clinician Utilization of Corus CAD (or ASGES) in Primary Care Provider Decision Making

An Assessment of the Glider Balloon in Complex Lesions

Echocardiography Guided Cardiac Resynchronization Therapy (EchoCRT)

Extension Phase of the Chronicle® Offers Management to Patients With Advanced Signs & Symptoms of Heart Failure Study

Pharmacodynamic Evaluation of Switching From Ticagrelor to Prasugrel in Subjects With Stable Coronary Artery Disease

Safety and Efficacy of Automatic Testing Feature in New ICDs and CRT-Ds

Cardiovascular Improvements With MV ASV Therapy in Heart Failure

Folic Acid for Vascular Outcome Reduction In Transplantation (FAVORIT)

Heart Outcomes Prevention and Evaluation 4

Prospective Multicenter Registry On RadiaTion Dose Estimates Of Cardiac CT AngIOgraphy IN Daily Practice in 2017

Pharmacist-led Group Medical Visits to Help With Diabetes Management

Other Conditions in Dallas